These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The relationship of complement to allergic disease. Frank MM Ann Allergy; 1969 Oct; 27(10):490-9. PubMed ID: 4195889 [No Abstract] [Full Text] [Related]
5. Complement inactivation by serum from patients with acute and hypocomplementemic chronic glomerulonephritis. Pickering RJ; Gewurz H; Good RA J Lab Clin Med; 1968 Aug; 72(2):298-307. PubMed ID: 5671203 [No Abstract] [Full Text] [Related]
6. Mechanisms of hypocomplementemia in glomerulonephritis. West CD; Ruley EJ; Forristal J; Davis NC Kidney Int; 1973 Feb; 3(2):116-25. PubMed ID: 4576695 [No Abstract] [Full Text] [Related]
7. Immunopathological changes during immunosuppressive treatment of glomerulonephritis in systemic lupus erythematosus. Munthe E; Brodwall EK; Oyri A; Natvig JB Acta Med Scand; 1974 Oct; 196(4):291-9. PubMed ID: 4139879 [No Abstract] [Full Text] [Related]
8. Serial complement component alterations in acute glomerulonephritis and systemic lupus erythematosus. Kohler PF; Ten Bensel R Clin Exp Immunol; 1969 Feb; 4(2):191-202. PubMed ID: 4978055 [TBL] [Abstract][Full Text] [Related]
9. THE AETIOLOGY OF SYSTEMIC LUPUS ERYTHEMATOSUS. STEVENS KM Lancet; 1964 Sep; 2(7358):506-8. PubMed ID: 14172922 [No Abstract] [Full Text] [Related]
10. Deficiency of the fourth component of complement in man. Torisu M; Sonozaki H; Inai S; Arata M J Immunol; 1970 Mar; 104(3):728-37. PubMed ID: 4190973 [No Abstract] [Full Text] [Related]
11. Complement activation in renal disease. West CD Uremia Invest; 1984-1985; 8(3-4):225-35. PubMed ID: 6545495 [TBL] [Abstract][Full Text] [Related]
12. Serum C'3 lytic system in patients with glomerulonephritis. Spitzer RE; Vallota EH; Forristal J; Sudora E; Stitzel A; Davis NC; West CD Science; 1969 Apr; 164(3878):436-7. PubMed ID: 4180576 [TBL] [Abstract][Full Text] [Related]
13. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis. Perrin LH; Lambert PH; Miescher PA J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431 [TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of complement]. Wellek B; Opferkuch W Dtsch Med Wochenschr; 1973 Dec; 98(49):2356-61. PubMed ID: 4271713 [No Abstract] [Full Text] [Related]
16. [Clinical importance of the complement system (author's transl)]. Opferkuch W Immun Infekt; 1977 Feb; 5(1):5-10. PubMed ID: 321332 [TBL] [Abstract][Full Text] [Related]
17. [The immunologic age in medicine]. Bonomo L Policlinico Prat; 1968 May; 75(21):677-86. PubMed ID: 4186643 [No Abstract] [Full Text] [Related]
18. C1g precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states: characterization of high and low molecular weight types. Agnello V; Koffler D; Eisenberg JW; Winchester RJ; Kundel HG J Exp Med; 1971 Sep; 134(3 Pt 2):228s-241s. PubMed ID: 4998931 [No Abstract] [Full Text] [Related]
19. The complement system of man. 4. Ruddy S; Gigli I; Austen KF N Engl J Med; 1972 Sep; 287(13):642-6. PubMed ID: 4561829 [No Abstract] [Full Text] [Related]
20. Studies on chronic membranoproliferative glomerulonephritis with hypocomplementemia. Michael AF; Westberg NG; Fish AJ; Vernier RL J Exp Med; 1971 Sep; 134(3 Pt 2):208s-227s. PubMed ID: 5570751 [No Abstract] [Full Text] [Related] [Next] [New Search]